Kikuchi, H.; Amofa, E.; Mcenery, M.; Schey, S.A.; Ramasamy, K.; Farzaneh, F.; Calle, Y.
Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics. Cancers 2023, 15, 462.
https://doi.org/10.3390/cancers15020462
AMA Style
Kikuchi H, Amofa E, Mcenery M, Schey SA, Ramasamy K, Farzaneh F, Calle Y.
Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics. Cancers. 2023; 15(2):462.
https://doi.org/10.3390/cancers15020462
Chicago/Turabian Style
Kikuchi, Hugh, Eunice Amofa, Maeve Mcenery, Steve Arthur Schey, Karthik Ramasamy, Farzin Farzaneh, and Yolanda Calle.
2023. "Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics" Cancers 15, no. 2: 462.
https://doi.org/10.3390/cancers15020462
APA Style
Kikuchi, H., Amofa, E., Mcenery, M., Schey, S. A., Ramasamy, K., Farzaneh, F., & Calle, Y.
(2023). Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics. Cancers, 15(2), 462.
https://doi.org/10.3390/cancers15020462
